Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.
Overgaard J, Hansen HS, Overgaard M, Bastholt L, Berthelsen A, Specht L, Lindeløv B, Jørgensen K. Overgaard J, et al. Among authors: specht l. Radiother Oncol. 1998 Feb;46(2):135-46. doi: 10.1016/s0167-8140(97)00220-x. Radiother Oncol. 1998. PMID: 9510041 Clinical Trial.
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.
Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, Bentzen J, Bastholt L, Hansen O, Johansen J, Andersen L, Evensen JF. Overgaard J, et al. Among authors: specht l. Lancet. 2003 Sep 20;362(9388):933-40. doi: 10.1016/s0140-6736(03)14361-9. Lancet. 2003. PMID: 14511925 Clinical Trial.
The Danish national guidelines for treatment of oral squamous cell carcinoma.
Bilde A, von Buchwald C, Johansen J, Bastholt L, Sørensen JA, Marker P, Krogdahl A, Hansen HS, Specht L, Kirkegaard J, Andersen E, Bentzen J, Hjort-Sørensen C, Andersen LJ, Nielsen BA, Bundgaard T, Overgaard M, Grau C; Danish Society for Head and Neck Oncology. Bilde A, et al. Among authors: specht l. Acta Oncol. 2006;45(3):294-9. doi: 10.1080/02841860600592998. Acta Oncol. 2006. PMID: 16644572
Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck.
Bastholt L, Specht L, Jensen K, Brun E, Loft A, Petersen J, Kastberg H, Eriksen JG. Bastholt L, et al. Among authors: specht l. Radiother Oncol. 2007 Oct;85(1):24-8. doi: 10.1016/j.radonc.2007.06.007. Epub 2007 Jun 28. Radiother Oncol. 2007. PMID: 17602769 Clinical Trial.
394 results